Opinion|Videos|July 18, 2024
TARGET-DERM: A Real-World Study of Patient-Reported Outcomes in Atopic Dermatitis
Author(s)Shawn Kwatra, MD
An expert on skin conditions provides an overview of TARGET-DERM, a real-world study of patient-reported outcomes in atopic dermatitis.
Advertisement
Episodes in this series
Video content above is prompted by the following questions:
- Can you discuss recently presented data from TARGET-DERM, a longitudinal, observational study, on the effect of skin severity and itch (both independent and combined) on patients’ QoL (RAD 2024 meeting)?
- What do these data mean for clinicians?
Advertisement
Related to this article
In this Q&A, Armand explains why eczema visits spike during wildfire smoke events and how allergic patients can protect themselves.
In this feature, several leaders in the dermatology space were asked how far we have come and where the field is headed in precision medicine.
New research links wildfire smoke to lasting respiratory decline and skin flares, months after exposure ends.
Advertisement
Advertisement
Trending on HCPLive
1
FDA Updates Sotatercept Label with HYPERION Data in Early PAH
2
EMBARQ-CSU: Barzolvolimab Meets Primary, Secondary Endpoints in CSU Trials
3
FAQ: What the Expanded Marstacimab Approval Means for Hemophilia A, B
4
Half-Life vs. Real Life: How Real-World Evidence Is Reframing Wet AMD Treatment
5